Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group

V. Koblizek (Hradec Králové, Czech Republic)

Source: International Congress 2017 – Notable abstracts in asthma
Session: Notable abstracts in asthma
Session type: Oral Presentation
Number: 4675
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Koblizek (Hradec Králové, Czech Republic). Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group. 4675

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL)
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020




Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020


An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Efficacy of German Disease Management Program Asthma and COPD - a cross sectional evaluation
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019


GOLD ABCD assessment tool: Comparison of 2013 and 2017 classifications in the UK Clinical Practice Research Datalink (CPRD)
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Patient demographics and clinical characteristics in the UK Salford Lung Study (SLS COPD) and the European ACCESS study
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit
Source: International Congress 2017 – COPD management
Year: 2017

Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

The German COPD cohort COSYCONET: Aims, methods and results of recruitment
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial
Source: Eur Respir J, 51 (1) 1701567; 10.1183/13993003.01567-2017
Year: 2018



Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): a modified Delphi exercise to identify a core dataset for asthma and COPD studies
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020


Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


COPD severity using GOLD 2017 in real life: The French Palomb Cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018